Genetics study of methamphetamine use disorder in Thai people
Official title: Methamphetamine and Other Substance Use Disorder Genetics in Thailand
Funded at Yale University · NIH-11535768 · Data updated 2026-11-12
A genetics study in Thailand is looking at how genes may influence methamphetamine use disorder and related behaviors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | June 15, 2015 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $157,529 |
| NIH project number | 3R01DA037974-09S1 |
| Project ID | NIH-11535768 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are Thai individuals with methamphetamine use disorder or matched controls without MUD who are reachable through participating hospitals and community sites.
✕Less likely to help
Individuals not eligible due to not meeting criteria or not located in the study regions may not benefit directly.
What this research studies
This project aims to collect and characterize a large biobank of Thai individuals with and without methamphetamine use disorder to explore genetic factors. Researchers will recruit thousands of participants in Bangkok and Chiang Mai, obtaining DNA samples and detailed behavioral information. The study builds on established international collaborations and existing Thai research infrastructure to create a resource for understanding SUDs and other psychiatric traits. Results could help identify genetic risk factors and pave the way for personalized approaches to prevention and treatment in the Thai population.
Why it matters
Potential benefit: If successful, the findings could lead to better understanding of genetic risk for methamphetamine use disorder and inform more tailored prevention and treatment strategies for affected individuals.
How similar studies have gone: Previous large genetic studies of substance use disorders have identified risk variants, and this project continues that approach in a specific population with a robust biobank.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Gelernter, Joel — Yale University
- Study coordinator: Gelernter, Joel
Related research
Other NIH-funded projects on the same topics.
-
Co-treated care for substance use and heart infection at UVMMC
A hospital-based project aims to improve how doctors and teams treat people with both substance use disorder and infective endocarditis during their hospital stay.
-
PROTECT-ED: Rapid care connects people just released from jail to HIV and overdose prevention
A program in the emergency department helps people who just left jail get started on medications for opioid use disorder and HIV prevention right away and connect them to ongoing care.
-
Justice Core: Helping pregnant women with substance use get treatment while in jail
A pragmatic trial will test whether a jail diversion program (Justice Core) improves access to treatment and perinatal outcomes for pregnant women with substance use issues compared to usual referral after jail release.
-
Adapting with Proactive SUD Intervention via Disease Intervention Specialists
A new program uses a proven outreach model to identify and connect people with substance use disorder to care earlier, by applying DIS tactics to SUD in communities.
-
ED-based Screening and Brief Intervention to Prevent Substance Use Disorder
A Purdue-led project will test if ED-based screening plus a brief in-person motivational talk and follow-up telehealth coaching can reduce risky substance use and prevent future disorder in diverse adults.
-
Connecting Primary Care to SUD Treatment with Telehealth Collaborative Care
A Mayo Clinic study tests a telehealth-based collaborative care platform to help primary care clinics identify and treat substance use disorders in rural adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.